. During the evaluation of SRM 909c samples, a third method was developed using a pentafluorophenylpropyl column that also separates the diastereomers 25(OH)D 3 and 3-epi-25(OH)D 3 . The 25(OH)D 3 was measured in SRM 909c using all three methods, and the results were compared.
Introduction
Vitamin D is a prohormone that helps the body regulate calcium and phosphate metabolism and is important for bone health. Vitamin D exists primarily in two forms, as vitamin D 3 , which is native to animals and can be formed in the skin by reaction of UV light with 7-dehydrocholesterol, and as vitamin D 2 There are several different analytical techniques that can be used to measure 25(OH)D. Radioimmunoassay, enzyme immunoassay, and chemiluminescent immunoassay platform techniques are commonly used, but these assays do not differentiate between the 25(OH)D 2 and 25(OH)D 3 forms and may not provide equal responses for these two metabolites (see review of immunoassay methods in [1] ). Therefore, many clinical labs are using liquid chromatography (LC) with tandem mass spectrometric detection (MS/MS), which can provide quantitation of 25(OH)D 2 and 25(OH)D 3 through the proper selection of column and mobile phase conditions and/or by monitoring different mass transitions for each of the two metabolites. To date, there are several published methods for determining the vitamin D metabolites using LC-MS/MS, most of which use stable isotopically labeled standards such as [2] and Hoofnagle et al. [3] , which used labeled standards for both metabolites. Specific details of many published immunoassay and LC-MS/MS methods may be found in recent review articles [1, [4] [5] [6] , but several LC-MS/MS methods have subsequently been reported [7] [8] [9] [10] [11] [12] [13] [14] .
Liquid chromatography with single quadrupole mass spectrometric detection (LC-MS) has been overlooked as a useful technique for determining the vitamin D metabolites in human serum. Of the three reported literature methods [15] [16] [17] , two measured the metabolites directly [15, 17] , while the other used derivatization with an ion trap MS [16] . LC-MS has significant advantages over LC-MS/MS methods including ease of use and affordability. While potential disadvantages exist such as increased susceptibility to matrix interferences and decreased sensitivity, these obstacles can often be overcome by optimization of the analytical separation conditions and sample clean-up procedures.
In [18] . To determine if 3-epi-25(OH)D 3 is present as a metabolite in human serum, this diastereomer must be chromatographically resolved from 25(OH)D 3 because these compounds produce the same ions and cannot be distinguished solely with MS or MS/MS detection. Singh et al. used LC-MS/MS with a chiral column that separated the diastereomers and identified 3-epi-25(OH)D 3 as a major component in the human serum of infants [19] . Most LC-MS/MS methods utilize C18 columns, which do not resolve these compounds and create a potential bias if significant 3-epi-25(OH)D 3 is present in the sample. For the few reported methods that use columns and mobile phase conditions that resolve these diastereomers, the 3-epi-25(OH)D 3 is frequently detected in serum collected from adults [2, 9, [20] [21] [22] [23] [24] . In a recent study that evaluated the prevalence of 3-epi-25(OH)D 3 in serum samples collected from 501 patients aged 1-94 years, the percentage of 3-epi-25(OH)D 3 (relative to the 25(OH)D 3 ) ranged from 0% to 61% [24] .
To address the lack of LC-MS methods for determining 25 [20] . Both methods were used for the certification measurements of Standard Reference Material (SRM) 972 Vitamin D in Human Serum, which was developed by the National Institute of Standards and Technology (NIST) to support accurate measurements of vitamin D metabolites in the clinical community. SRM 972 consists of four Levels with different concentrations of 25(OH)D 3 , 25(OH)D 2 , and 3-epi-25(OH)D 3 ; details about the preparation and certification measurements of SRM 972 are reported elsewhere [22] . NIST is also providing certified values for the vitamin D metabolites in SRM 909c Human Serum, which has been characterized for other important clinical analytes such as cholesterol, creatinine, and glucose. When SRM 909c was subsequently evaluated using the C18 and CN methods, several matrix interferences were observed, and the methods required modification. This manuscript details the development of the C18 and CN LC-MS methods used for the certification measurements of SRM 972, the modification of these methods for SRM 909c samples, and the development of a third method using a pentafluorophenylpropyl (PFPP) analytical column that also separates 25(OH)D 3 and 3-epi-25(OH)D 3 . The 25(OH)D 3 in both SRM 909c and SRM 972 Level 1 (measurement control) was successfully quantitated using all three methods. The use of multiple chromatographic separation methods was important for identifying and quantitating the vitamin D metabolites in complex matrix samples like SRM 909c. 1 Certain commercial equipment, instruments, or materials are identified in this paper to specify adequately the experimental procedure. Such identification does not imply recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose. 1 
Materials and methods

Materials
The reference standard for 25- 
Instrumentation
An Agilent Technologies (Palo Alto, CA, USA) 1100 series LC with an SL series MS detector and an APCI source was used to determine vitamin D metabolites. The following three optimized chromatographic methods were used to determine 25(OH)D in SRM 909c.
The first method used a Luna C18(2) column with dimensions 250 mm × 4.6 mm ID and 5 m particles and a 3.0 mm × 4 mm C18 Security Guard column (Phenomenex, Torrance, CA, USA). The column temperature was maintained at 15 • C, and the mobile phase composition used to separate 25(OH)D 2 and 25(OH)D 3 was 7% water, 93% methanol (volume fractions) at 1.0 mL/min for 11 min. When serum samples were injected, a step gradient was incorporated into the method at the end of the run to elute retained matrix constituents. The step gradient was from 93% methanol to 100% methanol from 11 min to 14 min, followed by a hold at 100% methanol until 26 min. The MS was turned off at 12 min into the run to avoid contamination of the MS with the long-retained components. After returning to the initial conditions, a post-run time of 7 min was used to allow equilibration prior to injection of the next sample. Injection volumes of 15 L were used.
The second method utilized a Zorbax SB-CN column that was 250 mm × 4.6 mm ID with 5 m particles and a corresponding guard column that was 12.5 mm × 4.6 mm ID (Agilent). The column temperature was maintained at 45 • C, and an isocratic mobile phase of 32% water, 68% methanol at 1.0 mL/min for 27 min was used to provide separation of 25(OH)D 3 and 3-epi-25(OH)D 3 . As with the C18 column, a step gradient was incorporated into the method at the end of the run to elute retained matrix constituents. The step gradient was from 69% methanol to 100% methanol from 27 min to 29 min followed by a hold at 100% methanol from 29 to 39 min. The MS was turned off at 27 min into the run to avoid contamination of the MS with the long-retained components. After returning to the initial conditions, a post-run time of 7 min was used to allow equilibration prior to injection of the next sample. An injection volume of 15 L was used.
An Ascentis Express F5 (PFPP) column from Supelco (Bellefonte, PA, USA) with dimensions of 150 mm × 4.6 mm ID and 2.7 m particles and a corresponding guard column that was 5 mm × 4.6 mm ID was used for the third method. The column was maintained at a temperature of 15 • C, and an isocratic mobile phase of 26% water, 74% methanol at 0.8 mL/min for 25 min was used to provide separation of 25(OH)D 3 and 3-epi-25(OH)D 3 . A step gradient was employed when serum extracts were injected as a flush to remove long-retained compounds from the column. The step gradient was from 74% methanol to 100% methanol from 25 min to 27 min, followed by a hold at 100% methanol from 27 min to 37 min. The MS was turned off at 28 min into the run to avoid contamination of the MS with the long-retained components. After returning to the initial conditions, a post-run time of 10 min was used to allow equilibration prior to injection of the next sample. An injection volume of 7 L was used.
All Given the very low (ng/mL) levels of 25(OH)D 3 in serum, dilutions were required to achieve the target concentrations for the working calibrants. First, three stock solutions of 25(OH)D 3 were gravimetrically prepared to be 4.3-5.2 g/g by weighing 1-2 mg of reference standard in 500 mL ethanol (exact masses and concentrations known). From these stock solutions, three intermediate calibration solutions were gravimetrically prepared by weighing an exact amount of a stock solution and diluting with ethanol to 100 mL or 250 mL ethanol to yield solutions with 25(OH)D 3 concentrations ranging from 227 ng/g to 249 ng/g. These intermediate calibration solutions were then used to prepare three working calibrants by weighing fixed volumes of one of the intermediate calibration solutions and the IS solution. The concentration of 25(OH)D 3 in the working calibrants was designed to match the concentration in the injected SRM 909c samples (about 60 ng/g). All solutions were prepared in reduced lighting and were stored in amber bottles at −20 • C when not in use.
Preparation of SRM 909c samples
Ten samples were prepared for the determination of 25(OH)D 3 in SRM 909c that included single samples from each of two vials and duplicate samples from each of four vials. Duplicate samples were also prepared from a single vial of SRM 972 Level 1, which was analyzed as a measurement control. Prior to the preparation of samples, vials of SRM 909c and SRM 972 Level 1 were removed from the freezer, thawed at room temperature, and swirled gently to ensure thorough mixing. The sample preparation technique was based on a method for extracting the vitamin D metabolites from serum by Turpeinen et al. [25] . To prepare samples, approximately 110 mg (150 L) of internal standard was accurately weighed in an 8 mL glass tube with a screw cap. An additional 250 L of 20% isopropanol in methanol (volume fractions) not containing IS was added to have a sufficient volume for precipitation of serum proteins. Approximately 450 mg of an SRM sample was accurately weighed into the glass tube. The tubes were vortex-mixed and allowed to stand for 5 min. Next, 2 mL of hexane was added to the tube, which was then vortex-mixed for 30 s to extract the vitamin D metabolites. The samples were centrifuged at 314 rad/s (3000 rpm) for 20 min, after which 1.5 mL of the hexane layer was removed and transferred to a separate glass tube with a cap. A second extraction with 2 mL of hexane was performed, but the second time 2.0 mL of the hexane layer was removed and combined with the first extract. The hexane extracts were then evaporated to dryness at 40 • C under nitrogen. The residues were reconstituted with 200 L methanol, vortex-mixed, and analyzed using the three LC-MS methods. The autosampler tray was maintained at 15 • C to preserve the samples.
Evaluation of method performance
Five 1:3 serial dilutions of a 2119 ng/g 25(OH)D 3 solution were prepared by mass using ethanol as the diluent, with the final solution having a concentration of 2.168 ng/g. These solutions, in addition to an ethanol blank containing no 25(OH)D 3 , were used to determine the linearity, limits of detection (LOD), and limits of quantitation (LOQ) for the three reported LC-MS methods. The LOD was calculated using a signal to noise ratio of 3, while the LOQ was calculated as 10 times the signal to noise ratio. All methods were linear over the concentration range investigated. The LOD was determined to be 1 ng/g for the CN and PFPP methods, and 2 ng/g for the C18 method. The LOQ was determined to be 3 ng/g, 5 ng/g, and 6 ng/g for the CN, PFPP, and C18 methods, respectively. From these experiments, the optimized conditions listed in Section 2 were determined and were used for all methods. Different organic modifiers and mobile phase additives including methanol, acetonitrile, ammonium acetate, and trifluoroacetic acid were also investigated. As expected, the additives did not improve the ionization of 25(OH)D using APCI, and methanol was found to be a better ionization solvent than acetonitrile. Therefore, methanol/water mobile phases were used to develop the methods for 25(OH)D measurements.
Development of methods for determining 25(OH)D in SRM 972
The LC-MS methods were originally developed for the determination of the vitamin D metabolites in SRM 972. The initial experiments were focused on separating 25(OH)D 2 and 25(OH)D 3 because it was not believed that 3-epi-25(OH)D 3 would be a metabolite of concern in the adult serum materials that were used to prepare SRM 972. Most literature methods for determining the vitamin D metabolites use C18 columns, so several C18 columns from different vendors and with different dimensions were compared. All C18 columns evaluated readily separated 25(OH)D 2 and 25(OH)D 3 but were contaminated after multiple injections of serum-based samples, resulting in increased baseline noise and background ionization in the MS, particularly at the monitoring ion for 25(OH)D 3 (m/z 383). Changing the guard column more frequently and incorporating a gradient flush (to 100% methanol) at the end of every analysis helped to alleviate the issues with high background ionization, and these practices were followed for all LC-MS methods. Also, the use of a traditional analytical column with dimensions of 250 mm × 4.6 mm ID was better for the measurements of 25(OH)D because larger injection volumes could be used as well as higher flow rates, which benefits APCI/MS detection. A Luna C18(2) column was selected for the first method. The original conditions for the C18 column were developed using SRM 972 Level 3 as a test material because it contains significant levels of both 25(OH)D 3 (native) and 25(OH)D 2 (spiked). An isocratic mobile phased comprised of 90% methanol, 10% water (volume fractions) and a column temperature of 45 • C were found to separate the analytes from matrix peaks. These conditions were used to determine 25(OH)D 2 After developing the method with the CN column for SRM 972 Level 4, extracts of SRM 972 Level 1, Level 2, and Level 3 were also evaluated with the CN method. Representative chromatograms of a sample of SRM 972 Level 3 are presented in Fig. 3 . A large peak that elutes before the peak for 25(OH)D 3 is observable in the m/z 383 chromatogram and is displayed off-scale. Due to its large size, the compound is unlikely to be related to 25(OH)D 3 and was presumed to originate from the matrix. The development of chromatographic conditions that separated this interference from 25(OH)D 3 were critical because of the limited selectivity of MS detection for complex matrix samples like human serum. There is also a small peak in the m/z 383 chromatogram that elutes as a slight shoulder on the 25(OH)D 3 peak and has the correct retention time for 3-epi-25(OH)D 3 . This peak was also evident in the chromatograms for Level 1 and Level 2, and it was concluded that all Levels of SRM 972 contain detectable amounts of this diastereomer. To avoid bias in the measured values for 25(OH)D 3 , the CN method was used to measure this analyte in SRM 972. However, 25(OH)D 2 was measured using the C18 column method because of the improved sensitivity of detection and the low levels of this analyte in SRM 972 Levels 1, 2, and 4 (<3 ng/mL). The certified values for SRM 972 [22] were obtained from a combination of the measurements obtained with the LC-MS methods described here as well as the measurements from LC-MS/MS methods developed by both NIST [2] and the US Centers for Disease Control and Prevention [26] .
Optimization and development of methods for determining 25(OH)D in SRM 909c
Samples of SRM 909c were preliminarily evaluated using the previously described methods for both the C18 and CN columns and [ 2 H 6 ]-25(OH)D 3 as the internal standard. The metabolite 25(OH)D 2 was not detected using either method, and the presence of 3-epi-25(OH)D 3 in SRM 909c was not confirmed with the CN method. Therefore, 25(OH)D 3 was the only vitamin D metabolite detected in SRM 909c. However, interferences at m/z 389 were observed for SRM 909c samples that affected reliable determination of the [ 2 H 6 ]-25(OH)D 3 peak area for both the C18 and CN methods. Interferences at this ion were not previously observed for SRM 972 and were presumed to originate from the SRM 909c matrix. These matrix peaks could possibly represent other unidentified vitamin D metabolites, but identification of these compounds was beyond the scope of the present investigation.
Since [ 2 H 6 ]-25(OH)D 3 is used for quantitation of 25(OH)D 3 , the existing methods were optimized to achieve better separation of the internal standard and the matrix peaks for SRM 909c samples. First, the mobile phase conditions were varied for the C18 method, but decreasing the methanol content from 90% to 88% did not baseline resolve the matrix interferences and decreased the sensitivity at m/z 383 for detection of 25(OH)D 3 . The column temperature was then decreased so that the proportion of methanol in the mobile phase could be increased. Conditions of 93% methanol, 7% water and a column temperature of 15 • C were found to separate [ 2 H 6 ]-25(OH)D 3 from the matrix peaks for the C18 method.
The mobile phase compositions were also varied for the CN column in an attempt to resolve the matrix interferences at m/z 389. Mobile phase compositions from 65% to 67% methanol were investigated with a column temperature of 45 • C. A composition of 65% methanol was found to provide resolution of Chromatographic conditions could not be identified that resolved the matrix interferences on the CN column, so modifications in sample preparation were also investigated. Samples of SRM 909c were prepared with and without filtration, with different ratios of the precipitation solvent to serum, and with different protein precipitation solvents including 20% isopropanol in methanol (the original method solvent), ethanol, methanol, and acetonitrile. When the samples were compared with the CN method, none of the procedural changes eliminated the interferences with the 
Quantitative results for 25(OH)D 3 in SRM 909c
Samples of SRM 909c were evaluated with the modified C18 method, the new PFPP method, and the CN method. To prepare samples, the procedure described in Section 2 was used with [ 2 H 3 ]-25(OH)D 3 as the internal standard (25(OH)D 2 was not detected in SRM 909c). Example chromatograms of an SRM 909c sample obtained using the three methods are provided in Fig. 5 , and all methods demonstrate good sensitivity and selectivity for determining 25 (see chromatogram of SRM 972 in Fig. 3 ). The other matrix peaks present in each of the chromatograms were not identified.
Since the presence of 3-epi-25(OH)D 3 was not positively confirmed, only 25(OH)D 3 was measured in SRM 909c. Table 1 presents the quantitative results for 25(OH)D 3 in SRM 909c and SRM 972 Level 1, which was used as a control to validate the measurements. The data in Table 1 include the total number of quantitative values measured (N), the average value, the standard deviation (SD), and the percent relative standard deviation (%RSD); the reported concentrations of 25(OH)D 3 were corrected for the purity of the reference standard, which was determined at NIST. There is excellent agreement in the results obtained for all three methods for both materials, and the measurement variability was very low (%RSD < 2. indicating that the measurements were in control during the analysis of SRM 909c.
Conclusions
LC-APCI/MS methods using C18 and CN columns were developed to determine the vitamin D metabolites in SRM 972. The methods utilized optimized detection parameters, sample preparation, and separation conditions for resolution of matrix constituents from the analytes and labeled standards. When these methods were used to evaluate SRM 909c, matrix peaks were observed that interfered with the measurement of [ 2 H 6 ]-25(OH)D 3 and hence 25(OH)D 3 . The conditions for the C18 method were modified to separate the matrix peaks, but only selection of [ 2 H 3 ]-25(OH)D 3 as an internal standard eliminated the interference for the CN method. Since SRM 909c samples were found to have matrix peaks and interferences that were not present in the four Levels of SRM 972, multiple robust methods to accurately assess both the identity and concentrations of the vitamin D metabolites were necessary. Therefore, a third method that utilizes a PFPP column was also developed for evaluating SRM 909c samples. Of the two methods that resolve 25(OH)D 3 and 3-epi-25(OH)D 3 , the PFPP method offered better resolution over the CN method for the SRM 909c samples. However, since 3-epi-25(OH)D 3 was not detected in SRM 909c, the results for 25(OH)D 3 obtained with the C18 method were unbiased and found to be equivalent to the results obtained for the CN and PFPP methods.
